跳至主要内容
临床试验/NCT03092167
NCT03092167已完成不适用

Physical Training in Patients With Idiopathic Inflammatory Myopathies

University of Sao Paulo2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2017年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
2
主要终点
Cardiopulmonary test

研究概览

简要总结

Physical training may improve physical capacity and health parameters in various systemic autoimmune diseases, including idiopathic inflammatory myopathies. Therefore, the present study will assess the role of an exercise training program in patients with idiopathic inflammatory myopathies.

详细描述

To assess the impact of 12-weeks of physical training in patients with idiopathic inflammatory myopathies.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

盲法说明

Open label

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of DM / PM according to the criteria of Bohan and Peter (1975)
  • Both genders and age ≥ 18 years
  • Use of prednisone ≤ 0.5 mg/kg/day in the last three months. The dose of prednisone will be kept fixed throughout the study
  • Physically inactive

排除标准

  • Disease relapsing
  • Neoplasia associated-myositis
  • Overlapping myositis
  • Use of lipid-lowering drugs
  • Diabetes mellitus

结局指标

主要结局

Cardiopulmonary test

时间窗: 12 weeks

Patients will undertake a maximal graded exercise test on a treadmill, with increments in velocity and grade at every minute until volitional exhaustion. VO2peak will be considered as the average of the final 30 s of the test. Ventilatory threshold (VAT) will be determined when ventilatory equivalent for VO2 (VE/VO2) increased without a concomitant increase in ventilatory equivalent for carbon dioxide (VE/VCO2). Respiratory compensation point (RCP) will be determined when VE/VO2 and VE/VCO2 increased simultaneously.

次要结局

  • Functional muscle tests(12 weeks)
  • Strength muscle tests(12 weeks)
  • Patient/Parent Global Activity(12 weeks)
  • Serum cytokines(12 weeks)
  • Health Assessment Questionnaire(12 weeks)
  • Muscle biopsies(12 weeks)
  • Myositis Disease Activity Assessment Tool(12 weeks)
  • Muscle enzymes(12 weeks)
  • Manual Muscle Testing(12 weeks)
  • Physician Global Activity(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Samuel Katsuyuki Shinjo, PhD

Principal Investigator

University of Sao Paulo

研究点 (2)

Loading locations...

相似试验